The materials on this page are confidential and provided to prospective investors and partners under a non-disclosure agreement. Read the agreement, register, or sign in if you have registered before.
NON-DISCLOSURE AGREEMENT
This Agreement is entered into between Burmain Holdings (Pty) Ltd, a company registered in the Republic of South Africa ("Burmain"), and the individual registering below ("Recipient").
1. Purpose. The Recipient wishes to review confidential information relating to the BovRes BR-1 livestock monitoring collar, the HerdLink platform and the associated business of Burmain, solely to evaluate a potential investment in, partnership with, or commercial relationship with Burmain (the "Purpose").
2. Confidential Information. All non-public information disclosed on this site, in the data room or otherwise in connection with the Purpose, including technical designs, firmware and algorithms, study protocols and results, financial projections, business plans, partner and customer identities, and the existence and terms of any discussions. It excludes information that is or becomes public through no fault of the Recipient, was lawfully known to the Recipient before disclosure, is independently developed without use of the Confidential Information, or is lawfully received from a third party without restriction.
3. Obligations. The Recipient shall use the Confidential Information only for the Purpose; keep it confidential using no less than reasonable care; disclose it only to advisers and colleagues who need to know for the Purpose and who are bound by equivalent obligations; and not reverse-engineer any hardware, software or samples provided.
4. Compelled disclosure. The Recipient may disclose Confidential Information to the extent required by law, giving Burmain prompt notice where lawful and disclosing only the minimum required.
5. No licence; no offer. No licence or right in any intellectual property is granted. Nothing on this site is an offer to the public of securities, a prospectus, or investment, legal or tax advice. Any investment would be made only under a separate written agreement negotiated with identified investors.
6. Return or destruction. On request or when the Purpose ends, the Recipient shall return or destroy Confidential Information, save for archival copies retained under continuing confidentiality.
7. Term. Obligations continue for five (5) years from each disclosure, and indefinitely for trade secrets.
8. Remedies. Breach may cause irreparable harm; Burmain may seek interdictory relief in addition to any other remedy.
9. Governing law. The laws of the Republic of South Africa; jurisdiction of the High Court of South Africa, Western Cape Division, Cape Town.
10. Data. Your name, email address, mobile number and access records are processed under the Protection of Personal Information Act for the Purpose only.
BovRes BR-1 is a South African-made, self-powered, off-grid cattle collar and platform that detects the onset of fever and behaviour change one to three days before an animal looks sick, and turns vaccinated herds into a surveillance network that farmers, processors and the state can act on.
The seed round Read the business planSouth Africa's 2025–26 FMD outbreak is the worst on record. A national disaster was declared in February 2026; beef exports fell 36%; dairy losses passed R1 billion at about R5,000 per affected cow; BFAP projects R3.2–11.3 billion of beef-sector losses to 2030.
Government is vaccinating 14 million cattle by December 2026 and new outbreaks in Gauteng are down 96%. But under WOAH rules, export status returns only when continuous clinical and serological surveillance proves the virus is no longer circulating in vaccinated herds. Vaccinated animals can still be infected and shed virus, with milder and later signs. The state veterinary service cannot physically inspect 14 million animals for the next 12–24 months.
Surveillance, not vaccination, is now the bottleneck to R1.8 billion or more of export earnings a year.
Evidence. Challenge studies: cattle transmit FMD at least 24 h before clinical signs; fever is the earliest sign (Arzt et al., Sci Rep 2025; Front Vet Sci 2025; Vet Res 2025). Sensor studies: rumen-temperature boluses detect fever 12–136 h before clinical respiratory disease; behaviour sensors detect change 5–7 days before (Vet J 2011; Animals 2024). Continuous temperature and behaviour monitoring is an established, commercially proven method; BR-1 applies it to the outbreak-surveillance problem at a South African price point.
BR-1 does not treat, prevent or cure any disease and no such claim is made. It is regulated as electronics (ICASA/SABS), not as a veterinary medicine. All performance claims will come from independent, pre-registered studies.
For the farmer. Traffic-light dashboard; same-day alerts for fever, activity collapse, rumination drop, lameness, mastitis and heat; find-the-animal locator; LITS-SA movement log. R25 / animal / month.
For state vets and DALRRD. District anomaly clustering and contact tracing; continuous "no clinical signs" evidence per farm for WOAH-compliant surveillance and export re-certification. Licensed per district.
For processors, exporters, insurers. Verification that supplying herds were continuously monitored with no unresolved alerts for the required period. Licensed per buyer.
| SenseHub (MSD) | smaXtec | Ceres Tag | BovRes BR-1 | |
|---|---|---|---|---|
| Designed for | Per-cow productivity | Dairy core temp | Location, theft | Outbreak early warning + productivity |
| Connectivity | Base stations | Cellular | Satellite | Off-grid LoRaWAN mesh |
| Indicative price | R4,000–8,000 + sub | Bolus + sub | High per-tag | R2,499 + R25/mo |
| Surveillance / state use | No | No | No | Built in |
| Manufacture | Imported | Imported | Imported | South African |
Global precision livestock farming by 2030, 8.8% CAGR (MarketsandMarkets)
SA cattle vaccinated in 2026; each one a surveillance obligation
head in commercial beef, dairy and feedlots in FMD-affected provinces: >R10bn hardware, R1.2–1.5bn/yr software
active units targeted by 2030: under 2% of the serviceable market
| Segment | Why they buy | When |
|---|---|---|
| Feedlots (c. 70; ~1.2 m head) | BRD morbidity 10–20%; earlier treatment cuts relapse and mortality; collars re-used 3–4 cycles a year | Beachhead, 2027 |
| Commercial dairies | R5,000 per cow lost per FMD case; mastitis and heat detection pay the subscription; monitored herds ease milk-movement certification | Beachhead, 2027 |
| Provincial vets / DALRRD | Cannot inspect 14 m animals; KZN alone redirected R400 m to FMD control; a surveillance licence costs less than one vet post | 2027–28 |
| Processors, exporters, insurers | Proof of monitored, alert-free supply for export certification and underwriting | 2028 |
| Extensive beef and communal farmers | GPS variant via RPO, co-ops and agri-retailers; Land Bank blended finance and donor programmes convert cost to monthly | 2028+ |
30 collars; accuracy vs reference thermometry; IP68/UV; 60-day power test; mesh range
100 animals (50 dairy, 50 feedlot), 12 weeks, blinded daily clinical scoring by a South African veterinary faculty
Farms under FMD restriction with provincial vets; confirmed cases as the reference
2,000+ animals in one district; dashboard used by state vets; publication submitted
Targets: sensitivity ≥80%, specificity ≥90% for clinical illness; median lead time ≥24 h (goal 48 h) ahead of visual detection. Partner: University of Pretoria Faculty of Veterinary Science (Onderstepoort) or UKZN, with ARC-OVR laboratory support. Pre-registered, ethics-approved, published regardless of outcome. Provisional patent filed (SA, PT/PV/ZA00002396); complete specification to cover the mesh collar architecture, the baseline/anomaly method and herd-level outbreak inference.
ZAR thousands. Conservative case, South Africa only; excludes surveillance and assurance licences, licensing income and export markets, all upside.
| 2026 | 2027 | 2028 | 2029 | 2030 | |
|---|---|---|---|---|---|
| Units sold | 100 | 2,000 | 8,000 | 22,000 | 45,000 |
| Active units | 100 | 2,100 | 10,100 | 32,100 | 77,100 |
| Revenue | 146 | 5,380 | 22,030 | 61,880 | 130,005 |
| Gross margin | 10% | 63% | 69% | 73% | 75% |
| EBITDA | (2,885) | (3,812) | 662 | 18,932 | 54,903 |
Acquisition by an animal-health major consolidating monitoring (MSD/Allflex, Zoetis, Boehringer Ingelheim, Ceva, Elanco) or platform licensing across FMD-endemic markets. Comparable transactions: Zoetis / Performance Livestock Analytics; MSD / Allflex (US$2.4 bn) and Antelliq.
In parallel: TIA Seed Fund / Technology Development Fund application (non-dilutive, R1–3 m) and IDC local-manufacturing support.
Terms, instrument and valuation are discussed directly with identified investors and documented in a separate agreement. Nothing on this page is an offer to the public.
Baden Dennis, Founder & CEO: product, AI/automation and nanomaterials applications; 15+ years in business development, capital raising and investor relations (GeoDax Holdings, StoneHedge, SPCF-IE).
Seed hires: lead embedded/RF engineer; data scientist / ML engineer; full-stack developer. Advisory board forming: veterinary epidemiologist (FMD), feedlot/dairy operator, animal-health commercial executive, regulatory/ICASA specialist.
Request the data room invitation, a call, or the full pack (Business Plan v4.0, Technical Overview v1.0, Pitch Deck v4.0):
bd@burmain.com · +27 71 671 5621 · Cape Town, South Africa